Biotech Target N V - Jul 19, 2021 Form 4 Insider Report for Molecular Templates, Inc. (MTEM)

Role: 10%+ Owner
Signature: /s/ Daniel Koller
Stock symbol: MTEM
Transactions as of: Jul 19, 2021
Transactions value $: $1,722,502
Form type: 4
Date filed: 7/21/2021, 02:02 PM
Previous filing: Jun 23, 2021
Next filing: Jul 28, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MTEM	Common Stock	Purchase	$831K	+119K	+1.25%	$6.96^*	9.66M	Jul 19, 2021	Direct
transaction	MTEM	Common Stock	Purchase	$892K	+125K	+1.29%	$7.13^*	9.79M	Jul 20, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.